Urbach DR et al. (2005) A measure of disease-specific health-related quality of life for achalasia. Am J Gastroenterol 100: 1668–1676
The optimal management of achalasia is controversial and there is a paucity of high-quality evidence from randomized trials comparing the effectiveness of different treatments and interventions. The absence of a valid and reliable measure of outcome is a particular problem: given that achalasia is not curable, improvements in symptoms and quality of life are the main goals of therapy and, therefore, a measure quantifying disease-specific quality of life is required.
Urbach and colleagues aimed to develop a measure of disease-specific quality of life with interval-level properties that could be applied in clinical trials. A list of 37 potential items for inclusion was derived from interviews with seven achalasia sufferers and expert opinion. Responses to a questionnaire sent to 70 individuals with achalasia were used to reduce the number of items to 10. Items ultimately selected for inclusion covered aspects of food tolerance, dysphagia-related behavior modifications, pain, heartburn, distress, lifestyle limitation and satisfaction. The measure was then recalibrated on to a 0–100 interval-level scale, where higher values indicate greater disease severity. Tests showed that the measure was reliable, had a wide effective measurement range and showed evidence of validity.
Although further work is needed to evaluate the reliability of the scale in different populations and to determine what constitutes a clinically meaningful change in scores, this scale appears to be suitable for use as an outcome measure in clinical trials and other evaluative studies of achalasia treatments.
Rights and permissions
About this article
Cite this article
Lovegrove, C. A new measure of disease-specific quality of life in achalasia. Nat Rev Gastroenterol Hepatol 2, 502 (2005). https://doi.org/10.1038/ncpgasthep0304
Issue Date:
DOI: https://doi.org/10.1038/ncpgasthep0304